Diagnostic Registration Consultant in Noida
Diagnostic Registration Consultant in Noida: The Complete Guide for Labs and Pathology Centers Healthcare in India is growing fast, and the demand for labs, pathology…
Regulatory Updates
BIS FMCS 2026: Complete Guide for Foreign Manufacturers Entering India
BIS has made FMCS applications fully digital from 1 June 2026, while a new electrical appliances QCO adds 90+ product categories with an October 2026 deadline. Here’s what foreign manufacturers must do now.
Knowledge Base
CDSCO SaMD Guidance 2025–26: What India’s Digital Health Companies Must Do Now
CDSCO’s October 2025 draft guidance on Medical Device Software is reshaping how SaMD and AI/ML tools are classified and licensed in India. Here’s what you need to act on.
Regulatory Updates
BIS Mandatory Certification Expands: New Rules for 2026
BIS adds furniture to mandatory certification, extends Scheme X deadline to September 2026, and expands CRS to 70+ electronics categories.
Regulatory Updates
CDSCO Cosmetic Import Registration: 2026 Step-by-Step Guide
India’s cosmetic import rules are tightening in 2026. This practical guide covers COS-1 to COS-2 approval, fees, timelines, and post-approval compliance under the Cosmetics Rules, 2020.
Regulatory Updates
Battery & E-Waste EPR: India’s 2025–26 Compliance Shake-Up
India’s Battery Waste and E-Waste EPR frameworks have been significantly tightened for FY 2025–26 and beyond. Here’s what producers and importers must do now.
Regulatory Updates
Plastic Waste Rules 2026: What Producers & Importers Must Do Now
India’s PWM Amendment Rules 2026 (G.S.R. 237(E)) impose binding recycled content targets, new importer obligations, and ₹1 crore penalties. Act before June 30.
CDSCO Public Notice on Disposal/Rejection of Long-Pending Applications on SUGAM Portal
he Central Drugs Standard Control Organization (CDSCO) has issued a new public notice dated 4 May 2026 regarding the disposal and rejection of long-pending applications
Regulatory Updates
FSSAI Nutraceuticals Licensing: 2026 Compliance Guide
The March 2026 FSSAI licensing overhaul changes the rules for nutraceutical FBOs — from perpetual validity to new thresholds. Here’s what you must do now.
Regulatory Updates
NDPS Act Compliance for Pharma: Key Updates in 2025–26
India’s NDPS regulatory landscape shifted significantly in late 2025 and early 2026. Here’s what pharmaceutical companies must act on now.